| lymphocyte differentiation | GO:0030098 | 242 | 0.879 | |
| negative regulation of cellular amino acid metabolic process | GO:0045763 | 0 | 0.784 | |
| negative regulation of cellular amine metabolic process | GO:0033239 | 1 | 0.771 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.586 | |
| leukocyte differentiation | GO:0002521 | 342 | 0.520 | |
| negative regulation of protein modification process | GO:0031400 | 163 | 0.490 | |
| positive t cell selection | GO:0043368 | 23 | 0.458 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.431 | |
| lymphocyte proliferation | GO:0046651 | 164 | 0.411 | |
| t cell differentiation in thymus | GO:0033077 | 77 | 0.408 | |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.393 | |
| v d j recombination | GO:0033151 | 14 | 0.381 | |
| lymphocyte homeostasis | GO:0002260 | 64 | 0.304 | |
| negative regulation of protein phosphorylation | GO:0001933 | 126 | 0.288 | |
| dna recombination | GO:0006310 | 92 | 0.286 | |
| positive regulation of regulatory t cell differentiation | GO:0045591 | 4 | 0.276 | |
| b cell homeostasis | GO:0001782 | 34 | 0.264 | |
| negative regulation of phosphorus metabolic process | GO:0010563 | 184 | 0.256 | |
| amine metabolic process | GO:0009308 | 45 | 0.233 | |
| dna repair | GO:0006281 | 107 | 0.232 | |
| immune response regulating signaling pathway | GO:0002764 | 125 | 0.203 | |
| response to endoplasmic reticulum stress | GO:0034976 | 53 | 0.198 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.187 | |
| regulation of cysteine type endopeptidase activity | GO:2000116 | 65 | 0.185 | |
| apoptotic process involved in mammary gland involution | GO:0060057 | 4 | 0.182 | |
| negative regulation of phosphate metabolic process | GO:0045936 | 184 | 0.175 | |
| regulation of alpha beta t cell differentiation | GO:0046637 | 35 | 0.166 | |
| cellular response to gamma radiation | GO:0071480 | 4 | 0.164 | |
| positive regulation of cell death | GO:0010942 | 224 | 0.163 | |
| leukocyte proliferation | GO:0070661 | 172 | 0.161 | |
| post embryonic organ morphogenesis | GO:0048563 | 8 | 0.159 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.158 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.157 | |
| b cell lineage commitment | GO:0002326 | 4 | 0.156 | |
| immune response activating cell surface receptor signaling pathway | GO:0002429 | 72 | 0.152 | |
| response to organonitrogen compound | GO:0010243 | 246 | 0.146 | |
| hematopoietic progenitor cell differentiation | GO:0002244 | 143 | 0.139 | |
| t cell activation | GO:0042110 | 289 | 0.137 | |
| t cell receptor v d j recombination | GO:0033153 | 5 | 0.133 | |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.130 | |
| thymus development | GO:0048538 | 41 | 0.129 | |
| regulation of b cell mediated immunity | GO:0002712 | 37 | 0.121 | |
| regulation of interleukin 10 secretion | GO:2001179 | 4 | 0.117 | |
| cytokine metabolic process | GO:0042107 | 71 | 0.116 | |
| mitochondrial outer membrane permeabilization involved in programmed cell death | GO:1902686 | 11 | 0.116 | |
| protein processing | GO:0016485 | 163 | 0.115 | |
| response to ionizing radiation | GO:0010212 | 42 | 0.115 | |
| regulation of mitochondrion organization | GO:0010821 | 27 | 0.114 | |
| regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043281 | 62 | 0.112 | |
| somatic diversification of immune receptors | GO:0002200 | 53 | 0.109 | |
| response to oxidative stress | GO:0006979 | 123 | 0.109 | |
| negative regulation of phosphorylation | GO:0042326 | 166 | 0.108 | |
| cd4 positive or cd8 positive alpha beta t cell lineage commitment | GO:0043369 | 8 | 0.106 | |
| antigen receptor mediated signaling pathway | GO:0050851 | 64 | 0.106 | |
| leukocyte homeostasis | GO:0001776 | 79 | 0.106 | |
| lymphocyte mediated immunity | GO:0002449 | 139 | 0.105 | |
| organ growth | GO:0035265 | 117 | 0.104 | |
| regulation of peptidase activity | GO:0052547 | 96 | 0.102 | |
| embryonic limb morphogenesis | GO:0030326 | 126 | 0.099 | |
| protein modification by small protein conjugation or removal | GO:0070647 | 207 | 0.096 | |
| immunoglobulin production | GO:0002377 | 73 | 0.094 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.094 | |
| regulation of lymphocyte activation | GO:0051249 | 240 | 0.093 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.092 | |
| dephosphorylation | GO:0016311 | 129 | 0.092 | |
| regulation of b cell differentiation | GO:0045577 | 23 | 0.091 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.091 | |
| response to inorganic substance | GO:0010035 | 96 | 0.091 | |
| activation of immune response | GO:0002253 | 138 | 0.089 | |
| regulation of mammary gland involution | GO:1903519 | 4 | 0.088 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.088 | |
| apoptotic mitochondrial changes | GO:0008637 | 48 | 0.087 | |
| epidermis development | GO:0008544 | 187 | 0.086 | |
| t cell differentiation | GO:0030217 | 174 | 0.086 | |
| somatic recombination of immunoglobulin gene segments | GO:0016447 | 42 | 0.085 | |
| regulation of cellular response to oxidative stress | GO:1900407 | 19 | 0.082 | |
| cellular process regulating host cell cycle in response to virus | GO:0060154 | 3 | 0.082 | |
| skin development | GO:0043588 | 220 | 0.081 | |
| intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0008631 | 19 | 0.080 | |
| regulation of cell cycle phase transition | GO:1901987 | 77 | 0.079 | |
| cell adhesion | GO:0007155 | 329 | 0.077 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.075 | |
| kidney morphogenesis | GO:0060993 | 83 | 0.073 | |
| developmental programmed cell death | GO:0010623 | 41 | 0.073 | |
| positive regulation of skeletal muscle fiber development | GO:0048743 | 3 | 0.072 | |
| intrinsic apoptotic signaling pathway in response to dna damage | GO:0008630 | 57 | 0.072 | |
| somatic diversification of immune receptors via germline recombination within a single locus | GO:0002562 | 51 | 0.071 | |
| homeostasis of number of cells | GO:0048872 | 210 | 0.071 | |
| renal tubule development | GO:0061326 | 87 | 0.070 | |
| g1 s transition of mitotic cell cycle | GO:0000082 | 57 | 0.070 | |
| innate immune response | GO:0045087 | 157 | 0.068 | |
| t cell mediated immunity | GO:0002456 | 50 | 0.067 | |
| immunoglobulin mediated immune response | GO:0016064 | 69 | 0.065 | |
| positive regulation of protein homooligomerization | GO:0032464 | 3 | 0.065 | |
| positive regulation of hydrolase activity | GO:0051345 | 148 | 0.064 | |
| response to amino acid | GO:0043200 | 37 | 0.064 | |
| nephron development | GO:0072006 | 109 | 0.062 | |
| regulation of apoptotic signaling pathway | GO:2001233 | 197 | 0.061 | |
| small gtpase mediated signal transduction | GO:0007264 | 97 | 0.061 | |
| myotube differentiation | GO:0014902 | 105 | 0.060 | |
| defense response to other organism | GO:0098542 | 197 | 0.059 | |
| interleukin 10 secretion | GO:0072608 | 4 | 0.059 | |
| peptidyl serine phosphorylation | GO:0018105 | 74 | 0.058 | |
| lipid transport | GO:0006869 | 98 | 0.058 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.056 | |
| regulation of mitotic cell cycle phase transition | GO:1901990 | 73 | 0.055 | |
| anatomical structure homeostasis | GO:0060249 | 145 | 0.055 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.055 | |
| apoptotic process involved in embryonic digit morphogenesis | GO:1902263 | 3 | 0.054 | |
| cochlear nucleus development | GO:0021747 | 4 | 0.053 | |
| somatic recombination of t cell receptor gene segments | GO:0002681 | 5 | 0.053 | |
| peptidyl serine modification | GO:0018209 | 83 | 0.052 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.052 | |
| regulation of cell cycle process | GO:0010564 | 160 | 0.052 | |
| apoptotic process involved in morphogenesis | GO:0060561 | 25 | 0.052 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.051 | |
| lipid localization | GO:0010876 | 126 | 0.051 | |
| negative regulation of t cell activation | GO:0050868 | 65 | 0.049 | |
| positive regulation of growth | GO:0045927 | 104 | 0.049 | |
| cellular hyperosmotic salinity response | GO:0071475 | 0 | 0.049 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.049 | |
| multicellular organism growth | GO:0035264 | 161 | 0.048 | |
| regulation of membrane potential | GO:0042391 | 192 | 0.048 | |
| nephron tubule development | GO:0072080 | 84 | 0.047 | |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.047 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.047 | |
| spermatogenesis | GO:0007283 | 284 | 0.047 | |
| immunoglobulin secretion | GO:0048305 | 17 | 0.046 | |
| b cell differentiation | GO:0030183 | 78 | 0.046 | |
| regulation of cell cycle | GO:0051726 | 281 | 0.046 | |
| mitochondrion organization | GO:0007005 | 134 | 0.045 | |
| neuron maturation | GO:0042551 | 29 | 0.042 | |
| fibroblast apoptotic process | GO:0044346 | 9 | 0.042 | |
| lymphocyte apoptotic process | GO:0070227 | 54 | 0.042 | |
| mesenchyme development | GO:0060485 | 152 | 0.041 | |
| aromatic compound catabolic process | GO:0019439 | 286 | 0.041 | |
| positive regulation of apoptotic process involved in morphogenesis | GO:1902339 | 4 | 0.041 | |
| skeletal system development | GO:0001501 | 356 | 0.041 | |
| single organismal cell cell adhesion | GO:0016337 | 131 | 0.040 | |
| endoplasmic reticulum calcium ion homeostasis | GO:0032469 | 11 | 0.040 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.039 | |
| glucose homeostasis | GO:0042593 | 128 | 0.039 | |
| histone modification | GO:0016570 | 159 | 0.038 | |
| negative regulation of peptidyl serine phosphorylation | GO:0033137 | 10 | 0.038 | |
| ureteric bud morphogenesis | GO:0060675 | 62 | 0.038 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.038 | |
| cell killing | GO:0001906 | 67 | 0.038 | |
| humoral immune response | GO:0006959 | 57 | 0.038 | |
| negative regulation of peptidase activity | GO:0010466 | 46 | 0.038 | |
| telencephalon development | GO:0021537 | 186 | 0.037 | |
| tissue migration | GO:0090130 | 68 | 0.037 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.036 | |
| viral process | GO:0016032 | 41 | 0.036 | |
| protein modification by small protein conjugation | GO:0032446 | 187 | 0.036 | |
| interleukin 5 secretion | GO:0072603 | 2 | 0.036 | |
| positive regulation of proteolysis | GO:0045862 | 85 | 0.036 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process by cytochrome c | GO:0008635 | 4 | 0.035 | |
| mesonephric tubule development | GO:0072164 | 94 | 0.035 | |
| cation transport | GO:0006812 | 399 | 0.035 | |
| fertilization | GO:0009566 | 127 | 0.035 | |
| positive regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway | GO:1903378 | 3 | 0.034 | |
| chromatin organization | GO:0006325 | 206 | 0.034 | |
| post embryonic camera type eye development | GO:0031077 | 8 | 0.034 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.034 | |
| t cell lineage commitment | GO:0002360 | 13 | 0.033 | |
| regulation of intrinsic apoptotic signaling pathway | GO:2001242 | 61 | 0.032 | |
| camera type eye development | GO:0043010 | 266 | 0.032 | |
| b cell receptor signaling pathway | GO:0050853 | 20 | 0.032 | |
| t cell receptor signaling pathway | GO:0050852 | 46 | 0.032 | |
| negative regulation of synapse assembly | GO:0051964 | 3 | 0.032 | |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.032 | |
| regulation of neuron differentiation | GO:0045664 | 281 | 0.032 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.032 | |
| regulation of cytokine production | GO:0001817 | 266 | 0.031 | |
| renal system development | GO:0072001 | 225 | 0.031 | |
| cellular response to virus | GO:0098586 | 7 | 0.031 | |
| posttranscriptional regulation of gene expression | GO:0010608 | 155 | 0.031 | |
| nitrogen compound transport | GO:0071705 | 271 | 0.031 | |
| apoptotic signaling pathway | GO:0097190 | 306 | 0.031 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.031 | |
| dna metabolic process | GO:0006259 | 303 | 0.030 | |
| response to uv b | GO:0010224 | 5 | 0.030 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.030 | |
| positive regulation of killing of cells of other organism | GO:0051712 | 3 | 0.030 | |
| regulation of oxidative stress induced neuron intrinsic apoptotic signaling pathway | GO:1903376 | 3 | 0.030 | |
| positive regulation of intrinsic apoptotic signaling pathway | GO:2001244 | 25 | 0.030 | |
| nephron epithelium development | GO:0072009 | 92 | 0.030 | |
| negative regulation of protein serine threonine kinase activity | GO:0071901 | 49 | 0.030 | |
| regulation of killing of cells of other organism | GO:0051709 | 4 | 0.029 | |
| response to starvation | GO:0042594 | 65 | 0.029 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.029 | |
| negative regulation of lymphocyte activation | GO:0051250 | 91 | 0.029 | |
| response to drug | GO:0042493 | 75 | 0.029 | |
| t cell homeostasis | GO:0043029 | 35 | 0.029 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.029 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.029 | |
| regulation of developmental pigmentation | GO:0048070 | 14 | 0.029 | |
| b cell activation | GO:0042113 | 161 | 0.029 | |
| positive regulation of mammary gland involution | GO:1903521 | 4 | 0.028 | |
| peptidyl tyrosine dephosphorylation | GO:0035335 | 23 | 0.028 | |
| positive regulation of defense response | GO:0031349 | 124 | 0.028 | |
| apoptotic process involved in patterning of blood vessels | GO:1902262 | 6 | 0.028 | |
| leukocyte apoptotic process | GO:0071887 | 71 | 0.027 | |
| t cell apoptotic process | GO:0070231 | 39 | 0.027 | |
| positive regulation of b cell activation | GO:0050871 | 49 | 0.027 | |
| spleen development | GO:0048536 | 39 | 0.027 | |
| limb development | GO:0060173 | 166 | 0.027 | |
| cellular response to starvation | GO:0009267 | 57 | 0.027 | |
| cell aging | GO:0007569 | 35 | 0.026 | |
| activation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:0097296 | 2 | 0.026 | |
| positive regulation of alpha beta t cell differentiation | GO:0046638 | 28 | 0.026 | |
| response to acid chemical | GO:0001101 | 111 | 0.026 | |
| cellular response to organonitrogen compound | GO:0071417 | 145 | 0.026 | |
| ear development | GO:0043583 | 200 | 0.026 | |
| regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002822 | 87 | 0.026 | |
| double strand break repair via nonhomologous end joining | GO:0006303 | 10 | 0.026 | |
| mitochondrial outer membrane permeabilization | GO:0097345 | 10 | 0.026 | |
| regulation of protein processing | GO:0070613 | 96 | 0.026 | |
| immune effector process | GO:0002252 | 321 | 0.025 | |
| regulation of organ growth | GO:0046620 | 61 | 0.025 | |
| t cell proliferation | GO:0042098 | 120 | 0.025 | |
| positive regulation of extrinsic apoptotic signaling pathway | GO:2001238 | 34 | 0.025 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.025 | |
| developmental maturation | GO:0021700 | 193 | 0.025 | |
| regulation of ion transport | GO:0043269 | 215 | 0.025 | |
| zymogen activation | GO:0031638 | 41 | 0.025 | |
| regulation of interleukin 13 secretion | GO:2000665 | 2 | 0.025 | |
| serotonin production involved in inflammatory response | GO:0002351 | 4 | 0.025 | |
| defense response to virus | GO:0051607 | 68 | 0.025 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.024 | |
| regulation of secretion by cell | GO:1903530 | 249 | 0.024 | |
| regulation of protein localization | GO:0032880 | 231 | 0.024 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.024 | |
| cellular chemical homeostasis | GO:0055082 | 215 | 0.024 | |
| gland development | GO:0048732 | 330 | 0.024 | |
| negative regulation of endoplasmic reticulum calcium ion concentration | GO:0032471 | 3 | 0.024 | |
| cell substrate adhesion | GO:0031589 | 130 | 0.024 | |
| serotonin secretion involved in inflammatory response | GO:0002442 | 4 | 0.024 | |
| regulation of cell activation | GO:0050865 | 289 | 0.024 | |
| humoral immune response mediated by circulating immunoglobulin | GO:0002455 | 14 | 0.024 | |
| modulation by virus of host process | GO:0019054 | 2 | 0.023 | |
| regulation of isotype switching to igg isotypes | GO:0048302 | 10 | 0.023 | |
| chromatin modification | GO:0016568 | 187 | 0.023 | |
| thymocyte apoptotic process | GO:0070242 | 19 | 0.023 | |
| carbohydrate homeostasis | GO:0033500 | 128 | 0.023 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.023 | |
| t cell homeostatic proliferation | GO:0001777 | 4 | 0.023 | |
| positive regulation of striated muscle tissue development | GO:0045844 | 31 | 0.023 | |
| regulation of b cell apoptotic process | GO:0002902 | 13 | 0.023 | |
| microtubule based process | GO:0007017 | 236 | 0.023 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.023 | |
| ossification | GO:0001503 | 216 | 0.023 | |
| neuron death | GO:0070997 | 154 | 0.023 | |
| programmed necrotic cell death | GO:0097300 | 28 | 0.022 | |
| adaptive immune response | GO:0002250 | 155 | 0.022 | |
| skeletal system morphogenesis | GO:0048705 | 203 | 0.022 | |
| negative regulation of protein processing | GO:0010955 | 79 | 0.022 | |
| leukocyte migration | GO:0050900 | 124 | 0.022 | |
| protein homooligomerization | GO:0051260 | 43 | 0.022 | |
| protein secretion | GO:0009306 | 111 | 0.022 | |
| negative regulation of adaptive immune response | GO:0002820 | 25 | 0.022 | |
| macromolecule methylation | GO:0043414 | 120 | 0.022 | |
| embryonic epithelial tube formation | GO:0001838 | 130 | 0.022 | |
| protein insertion into mitochondrial membrane involved in apoptotic signaling pathway | GO:0001844 | 4 | 0.022 | |
| extracellular matrix organization | GO:0030198 | 147 | 0.022 | |
| post embryonic eye morphogenesis | GO:0048050 | 4 | 0.022 | |
| maintenance of apical basal cell polarity | GO:0035090 | 3 | 0.022 | |
| mitochondrion morphogenesis | GO:0070584 | 13 | 0.022 | |
| response to steroid hormone | GO:0048545 | 56 | 0.022 | |
| telomere capping | GO:0016233 | 4 | 0.022 | |
| protein acylation | GO:0043543 | 64 | 0.022 | |
| mitochondrial membrane organization | GO:0007006 | 26 | 0.022 | |
| nephron tubule morphogenesis | GO:0072078 | 68 | 0.021 | |
| mesenchymal cell differentiation | GO:0048762 | 107 | 0.021 | |
| carboxylic acid transport | GO:0046942 | 100 | 0.021 | |
| cellular ion homeostasis | GO:0006873 | 165 | 0.021 | |
| stem cell development | GO:0048864 | 219 | 0.021 | |
| regulation of organ morphogenesis | GO:2000027 | 144 | 0.021 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.021 | |
| negative regulation of cell cycle | GO:0045786 | 123 | 0.021 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.021 | |
| mesonephros development | GO:0001823 | 97 | 0.021 | |
| regulation of t cell activation | GO:0050863 | 170 | 0.021 | |
| regulation of peptidyl serine phosphorylation | GO:0033135 | 39 | 0.020 | |
| rna phosphodiester bond hydrolysis endonucleolytic | GO:0090502 | 10 | 0.020 | |
| endodermal cell fate specification | GO:0001714 | 4 | 0.020 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.020 | |
| positive regulation of neuron death | GO:1901216 | 28 | 0.020 | |
| meiotic cell cycle | GO:0051321 | 122 | 0.020 | |
| ubiquitin dependent protein catabolic process | GO:0006511 | 129 | 0.020 | |
| regulation of nitrogen utilization | GO:0006808 | 2 | 0.020 | |
| immune response regulating cell surface receptor signaling pathway | GO:0002768 | 80 | 0.020 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.020 | |
| regulation of endopeptidase activity | GO:0052548 | 89 | 0.020 | |
| regulation of cytokine biosynthetic process | GO:0042035 | 59 | 0.020 | |
| alpha beta t cell differentiation | GO:0046632 | 69 | 0.020 | |
| embryonic appendage morphogenesis | GO:0035113 | 126 | 0.020 | |
| somatic diversification of t cell receptor genes | GO:0002568 | 5 | 0.020 | |
| response to retinoic acid | GO:0032526 | 56 | 0.020 | |
| positive regulation of myeloid leukocyte mediated immunity | GO:0002888 | 14 | 0.020 | |
| regulation of mitotic cell cycle | GO:0007346 | 126 | 0.020 | |
| response to insulin | GO:0032868 | 100 | 0.019 | |
| multicellular organismal response to stress | GO:0033555 | 62 | 0.019 | |
| hormone metabolic process | GO:0042445 | 86 | 0.019 | |
| regulation of neuron death | GO:1901214 | 134 | 0.019 | |
| non recombinational repair | GO:0000726 | 10 | 0.019 | |
| oocyte differentiation | GO:0009994 | 35 | 0.019 | |
| response to alkaloid | GO:0043279 | 34 | 0.019 | |
| regulation of interleukin 5 secretion | GO:2000662 | 2 | 0.019 | |
| neuron intrinsic apoptotic signaling pathway in response to oxidative stress | GO:0036480 | 3 | 0.019 | |
| muscle tissue development | GO:0060537 | 308 | 0.019 | |
| muscle cell differentiation | GO:0042692 | 261 | 0.019 | |
| peptidyl threonine modification | GO:0018210 | 31 | 0.019 | |
| mesonephric tubule morphogenesis | GO:0072171 | 63 | 0.018 | |
| meiotic nuclear division | GO:0007126 | 115 | 0.018 | |
| regulation of leukocyte differentiation | GO:1902105 | 159 | 0.018 | |
| skeletal muscle organ development | GO:0060538 | 163 | 0.018 | |
| response to growth factor | GO:0070848 | 198 | 0.018 | |
| limb morphogenesis | GO:0035108 | 149 | 0.018 | |
| somatic diversification of immunoglobulins involved in immune response | GO:0002208 | 36 | 0.018 | |
| notch signaling pathway | GO:0007219 | 71 | 0.018 | |
| positive regulation of mitochondrial membrane permeability involved in apoptotic process | GO:1902110 | 11 | 0.018 | |
| regulation of mammary gland epithelial cell proliferation | GO:0033599 | 12 | 0.018 | |
| alpha beta t cell activation | GO:0046631 | 91 | 0.018 | |
| pigment metabolic process | GO:0042440 | 32 | 0.018 | |
| modification by symbiont of host morphology or physiology | GO:0044003 | 4 | 0.018 | |
| nephron morphogenesis | GO:0072028 | 69 | 0.018 | |
| regulation of epithelial cell proliferation | GO:0050678 | 141 | 0.018 | |
| cellular homeostasis | GO:0019725 | 240 | 0.018 | |
| protein ubiquitination | GO:0016567 | 171 | 0.018 | |
| positive regulation of developmental pigmentation | GO:0048087 | 6 | 0.018 | |
| negative regulation of secretion | GO:0051048 | 61 | 0.018 | |
| positive regulation of cell development | GO:0010720 | 237 | 0.018 | |
| somatic diversification of immunoglobulins | GO:0016445 | 43 | 0.018 | |
| purine containing compound catabolic process | GO:0072523 | 213 | 0.018 | |
| negative regulation of antigen receptor mediated signaling pathway | GO:0050858 | 16 | 0.017 | |
| response to peptide | GO:1901652 | 136 | 0.017 | |
| fear response | GO:0042596 | 33 | 0.017 | |
| regulation of dna methylation | GO:0044030 | 12 | 0.017 | |
| somatic cell dna recombination | GO:0016444 | 51 | 0.017 | |
| metencephalon development | GO:0022037 | 89 | 0.017 | |
| regulation of pigment cell differentiation | GO:0050932 | 7 | 0.017 | |
| response to hydrogen peroxide | GO:0042542 | 32 | 0.017 | |
| maintenance of location | GO:0051235 | 89 | 0.017 | |
| gtp catabolic process | GO:0006184 | 143 | 0.017 | |
| glomerulus development | GO:0032835 | 40 | 0.017 | |
| male gamete generation | GO:0048232 | 285 | 0.017 | |
| multi multicellular organism process | GO:0044706 | 109 | 0.017 | |
| developmental pigmentation | GO:0048066 | 40 | 0.017 | |
| cellular response to dna damage stimulus | GO:0006974 | 207 | 0.017 | |
| membrane fusion | GO:0061025 | 38 | 0.017 | |
| negative regulation of mitotic cell cycle phase transition | GO:1901991 | 45 | 0.017 | |
| maintenance of epithelial cell apical basal polarity | GO:0045199 | 2 | 0.017 | |
| response to peptide hormone | GO:0043434 | 127 | 0.017 | |
| regulation of adaptive immune response | GO:0002819 | 90 | 0.017 | |
| peptide hormone secretion | GO:0030072 | 109 | 0.016 | |
| regulation of ion transmembrane transport | GO:0034765 | 119 | 0.016 | |
| regulation of cell maturation | GO:1903429 | 13 | 0.016 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.016 | |
| glycolipid metabolic process | GO:0006664 | 25 | 0.016 | |
| regulation of regulatory t cell differentiation | GO:0045589 | 7 | 0.016 | |
| regulation of gtp catabolic process | GO:0033124 | 113 | 0.016 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic signaling pathway | GO:2001269 | 3 | 0.016 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.016 | |
| tissue homeostasis | GO:0001894 | 115 | 0.016 | |
| cerebral cortex development | GO:0021987 | 86 | 0.016 | |
| kidney epithelium development | GO:0072073 | 121 | 0.016 | |
| vesicle organization | GO:0016050 | 60 | 0.016 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.016 | |
| intrinsic apoptotic signaling pathway | GO:0097193 | 132 | 0.016 | |
| labyrinthine layer blood vessel development | GO:0060716 | 21 | 0.016 | |
| modulation by symbiont of host cellular process | GO:0044068 | 2 | 0.016 | |
| response to radiation | GO:0009314 | 165 | 0.016 | |
| mitochondrial transport | GO:0006839 | 36 | 0.016 | |
| b cell selection | GO:0002339 | 3 | 0.016 | |
| erk1 and erk2 cascade | GO:0070371 | 77 | 0.015 | |
| urogenital system development | GO:0001655 | 261 | 0.015 | |
| regulation of establishment of protein localization | GO:0070201 | 181 | 0.015 | |
| cell growth | GO:0016049 | 130 | 0.015 | |
| positive regulation of cellular response to oxidative stress | GO:1900409 | 6 | 0.015 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.015 | |
| forebrain development | GO:0030900 | 302 | 0.015 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.015 | |
| angiogenesis | GO:0001525 | 201 | 0.015 | |
| single organism cell adhesion | GO:0098602 | 156 | 0.015 | |
| negative regulation of peptidyl tyrosine phosphorylation | GO:0050732 | 17 | 0.015 | |
| metanephros development | GO:0001656 | 79 | 0.015 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.015 | |
| negative regulation of protein transport | GO:0051224 | 46 | 0.015 | |
| regulation of cell morphogenesis involved in differentiation | GO:0010769 | 151 | 0.015 | |
| positive regulation of melanocyte differentiation | GO:0045636 | 5 | 0.015 | |
| regulation of protein homooligomerization | GO:0032462 | 3 | 0.014 | |
| purine ribonucleotide catabolic process | GO:0009154 | 208 | 0.014 | |
| pigmentation | GO:0043473 | 71 | 0.014 | |
| negative regulation of immune system process | GO:0002683 | 209 | 0.014 | |
| positive regulation of cytokine biosynthetic process | GO:0042108 | 40 | 0.014 | |
| coagulation | GO:0050817 | 78 | 0.014 | |
| positive regulation of cysteine type endopeptidase activity involved in apoptotic process | GO:0043280 | 36 | 0.014 | |
| negative regulation of fibroblast proliferation | GO:0048147 | 14 | 0.014 | |
| killing by symbiont of host cells | GO:0001907 | 2 | 0.014 | |
| development of primary female sexual characteristics | GO:0046545 | 73 | 0.014 | |
| fatty acid transport | GO:0015908 | 28 | 0.014 | |
| establishment of protein localization to organelle | GO:0072594 | 118 | 0.014 | |
| activation of cysteine type endopeptidase activity involved in apoptotic process | GO:0006919 | 27 | 0.014 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.014 | |
| positive regulation of homeostatic process | GO:0032846 | 64 | 0.014 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.014 | |
| modification dependent protein catabolic process | GO:0019941 | 133 | 0.014 | |
| nucleic acid phosphodiester bond hydrolysis | GO:0090305 | 49 | 0.014 | |
| negative regulation of cell proliferation | GO:0008285 | 296 | 0.014 | |
| positive regulation of pigment cell differentiation | GO:0050942 | 5 | 0.014 | |
| negative regulation of cytoplasmic transport | GO:1903650 | 29 | 0.014 | |
| negative regulation of notch signaling pathway | GO:0045746 | 14 | 0.014 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.014 | |
| somitogenesis | GO:0001756 | 69 | 0.014 | |
| regulation of lymphocyte differentiation | GO:0045619 | 107 | 0.014 | |
| genitalia development | GO:0048806 | 37 | 0.014 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.013 | |
| regulation of peptide transport | GO:0090087 | 91 | 0.013 | |
| dna modification | GO:0006304 | 50 | 0.013 | |
| apoptotic process involved in development | GO:1902742 | 28 | 0.013 | |
| b cell mediated immunity | GO:0019724 | 71 | 0.013 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.013 | |
| regulation of protein stability | GO:0031647 | 52 | 0.013 | |
| oogenesis | GO:0048477 | 56 | 0.013 | |
| regulation of b cell activation | GO:0050864 | 81 | 0.013 | |
| positive regulation of protein oligomerization | GO:0032461 | 4 | 0.013 | |
| integrin mediated signaling pathway | GO:0007229 | 27 | 0.013 | |
| b cell homeostatic proliferation | GO:0002358 | 2 | 0.013 | |
| regulation of leukocyte proliferation | GO:0070663 | 121 | 0.013 | |
| cellular protein complex assembly | GO:0043623 | 116 | 0.013 | |
| response to osmotic stress | GO:0006970 | 21 | 0.013 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.013 | |
| odontogenesis | GO:0042476 | 78 | 0.013 | |
| inorganic ion transmembrane transport | GO:0098660 | 234 | 0.013 | |
| glycosphingolipid metabolic process | GO:0006687 | 18 | 0.013 | |
| cellular response to decreased oxygen levels | GO:0036294 | 18 | 0.013 | |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.013 | |
| appendage development | GO:0048736 | 166 | 0.013 | |
| blood coagulation | GO:0007596 | 76 | 0.013 | |
| stem cell differentiation | GO:0048863 | 268 | 0.012 | |
| monocarboxylic acid transport | GO:0015718 | 44 | 0.012 | |
| protein maturation | GO:0051604 | 176 | 0.012 | |
| cellular metal ion homeostasis | GO:0006875 | 151 | 0.012 | |
| regulation of cell growth | GO:0001558 | 91 | 0.012 | |
| tube formation | GO:0035148 | 140 | 0.012 | |
| organic cyclic compound catabolic process | GO:1901361 | 295 | 0.012 | |
| negative regulation of organelle organization | GO:0010639 | 90 | 0.012 | |
| regulation of hydrolase activity | GO:0051336 | 246 | 0.012 | |
| negative regulation of inflammatory response to antigenic stimulus | GO:0002862 | 10 | 0.012 | |
| regulation of skeletal muscle fiber development | GO:0048742 | 36 | 0.012 | |
| nephron epithelium morphogenesis | GO:0072088 | 68 | 0.012 | |
| myotube cell development | GO:0014904 | 60 | 0.012 | |
| negative regulation of mitotic cell cycle | GO:0045930 | 58 | 0.012 | |
| neural tube closure | GO:0001843 | 90 | 0.012 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.012 | |
| respiratory system development | GO:0060541 | 190 | 0.012 | |
| embryonic digit morphogenesis | GO:0042733 | 56 | 0.011 | |
| wound healing | GO:0042060 | 157 | 0.011 | |
| positive regulation of cysteine type endopeptidase activity | GO:2001056 | 39 | 0.011 | |
| cytoplasmic transport | GO:0016482 | 234 | 0.011 | |
| regulation of cytoplasmic transport | GO:1903649 | 112 | 0.011 | |
| organic anion transport | GO:0015711 | 137 | 0.011 | |
| liposaccharide metabolic process | GO:1903509 | 27 | 0.011 | |
| regulation of system process | GO:0044057 | 200 | 0.011 | |
| cell matrix adhesion | GO:0007160 | 68 | 0.011 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.011 | |
| amide transport | GO:0042886 | 138 | 0.011 | |
| response to nitric oxide | GO:0071731 | 4 | 0.011 | |
| dna catabolic process | GO:0006308 | 19 | 0.011 | |
| regulation of epidermal growth factor receptor signaling pathway | GO:0042058 | 13 | 0.011 | |
| cellular protein catabolic process | GO:0044257 | 155 | 0.011 | |
| modulation by virus of host morphology or physiology | GO:0019048 | 3 | 0.011 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.011 | |
| heart morphogenesis | GO:0003007 | 178 | 0.011 | |
| cytokine biosynthetic process | GO:0042089 | 68 | 0.011 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.011 | |
| hindbrain development | GO:0030902 | 128 | 0.011 | |
| peptidyl threonine phosphorylation | GO:0018107 | 31 | 0.011 | |
| positive thymic t cell selection | GO:0045059 | 13 | 0.011 | |
| placenta development | GO:0001890 | 140 | 0.011 | |
| rhythmic process | GO:0048511 | 174 | 0.011 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.011 | |
